The weekly litigation news digest is live. Subscribe now

IP Verse

High Potency Pancreatin Pharmaceutical Compositions - EP3024479

The patent EP3024479 was granted to Allergan Pharmaceuticals on Feb 8, 2023. The application was filed on Jul 15, 2014 under application number EP14815008A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3024479

ALLERGAN PHARMACEUTICALS
Application Number
EP14815008A
Filing Date
Jul 15, 2014
Status
Patent Maintained As Amended
Jan 6, 2023
Publication Date
Feb 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MATHYS & SQUIREMar 5, 2020MATHYS & SQUIREADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2001046493
DESCRIPTIONUS2004057944
DESCRIPTIONUS6051220
DESCRIPTIONWO2006044529
INTERNATIONAL-SEARCH-REPORTCA2419572
INTERNATIONAL-SEARCH-REPORTEP0115023
INTERNATIONAL-SEARCH-REPORTUS2004057944
INTERNATIONAL-SEARCH-REPORTUS2006198838
OPPOSITIONUS3168448
OPPOSITIONUS3223594
OPPOSITIONWO2015069677

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents